John Mahlon Hutto, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1485 Festival Ln, Brutus, MI 49716 Phone: 231-529-6925 |
News Archive
Quality Partners of Rhode Island, the state's Medicare Quality Improvement Organization, has equipped Ocean State nursing homes working to reduce pressure ulcers with copies of the Pocket Guide to Pressure Ulcers, a new reference resource.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
New research shows it may be no accident when doctors observe how patients suffering from both breast cancer and arthritis seem to have more aggressive cancer. However, the new-found interaction between the two diseases may also suggest a possible treatment.
› Verified 8 days ago